1. Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer.
- Author
-
Nande R, Greco A, Gossman MS, Lopez JP, Claudio L, Salvatore M, Brunetti A, Denvir J, Howard CM, and Claudio PP
- Subjects
- Adenoviridae genetics, Animals, Apoptosis genetics, Apoptosis radiation effects, Benzothiazoles administration & dosage, Cell Line, Tumor, Drug Carriers administration & dosage, Drug Carriers pharmacology, Drug Delivery Systems methods, Female, Genes, p53, Genetic Therapy methods, Genetic Vectors administration & dosage, Humans, Luminescent Measurements, Male, Mice, Mice, Inbred BALB C, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology, Prostatic Neoplasms radiotherapy, Transgenes, X-Rays, Xenograft Model Antitumor Assays, Gene Transfer Techniques, Microbubbles therapeutic use, Prostatic Neoplasms therapy, Retinoblastoma Protein genetics, Retinoblastoma-Like Protein p130 genetics, Ultrasonography methods
- Abstract
Combining radiation therapy and direct intratumoral (IT) injection of adenoviral vectors has been explored as a means to enhance the therapeutic potential of gene transfer. A major challenge for gene transfer is systemic delivery of nucleic acids directly into an affected tissue. Ultrasound (US) contrast agents (microbubbles) are viable candidates to enhance targeted delivery of systemically administered genes. Here we show that p53, pRB, and p130 gene transfer mediated by US cavitation of microbubbles at the tumor site resulted in targeted gene transduction and increased reduction in tumor growth compared to DU-145 prostate cancer cell xenografts treated intratumorally with adenovirus (Ad) or radiation alone. Microbubble-assisted/US-mediated Ad.p53 and Ad.RB treated tumors showed significant reduction in tumor volume compared to Ad.p130 treated tumors (p<0.05). Additionally, US mediated microbubble delivery of p53 and RB combined with external beam radiation resulted in the most profound tumor reduction in DU-145 xenografted nude mice (p<0.05) compared to radiation alone. These findings highlight the potential therapeutic applications of this novel image-guided gene transfer technology in combination with external beam radiation for prostate cancer patients with therapy resistant disease.
- Published
- 2013
- Full Text
- View/download PDF